Stefan Holm

2.5k total citations
21 papers, 460 citations indexed

About

Stefan Holm is a scholar working on Genetics, Molecular Biology and Neurology. According to data from OpenAlex, Stefan Holm has authored 21 papers receiving a total of 460 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 9 papers in Molecular Biology and 5 papers in Neurology. Recurrent topics in Stefan Holm's work include Glioma Diagnosis and Treatment (10 papers), Brain Metastases and Treatment (4 papers) and Chromatin Remodeling and Cancer (4 papers). Stefan Holm is often cited by papers focused on Glioma Diagnosis and Treatment (10 papers), Brain Metastases and Treatment (4 papers) and Chromatin Remodeling and Cancer (4 papers). Stefan Holm collaborates with scholars based in Sweden, Germany and Denmark. Stefan Holm's co-authors include Per Kogner, Birgitta Lannering, Per‐Erik Sandström, Johan Lundgren, Susan Pfeifer, Bo Strömberg, Göran Gustafsson, Ulf Samuelsson, Bengt Gustavsson and Ute Bartels and has published in prestigious journals such as PLoS ONE, American Journal of Clinical Nutrition and Cancer.

In The Last Decade

Stefan Holm

19 papers receiving 450 citations

Peers

Stefan Holm
Neofytos Prodromou Greece
Steven Rostad United States
M Zavanone Italy
Peter Milos Sweden
Antonio E. Frias United States
S. Ali Nabavizadeh United States
Shyamala Navada United States
Martha Lilia Tena‐Suck Mexico
Louise Carstam Sweden
Neofytos Prodromou Greece
Stefan Holm
Citations per year, relative to Stefan Holm Stefan Holm (= 1×) peers Neofytos Prodromou

Countries citing papers authored by Stefan Holm

Since Specialization
Citations

This map shows the geographic impact of Stefan Holm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Holm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Holm more than expected).

Fields of papers citing papers by Stefan Holm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Holm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Holm. The network helps show where Stefan Holm may publish in the future.

Co-authorship network of co-authors of Stefan Holm

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Holm. A scholar is included among the top collaborators of Stefan Holm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Holm. Stefan Holm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pietsch, Torsten, Teresia Kling, Claes Nordborg, et al.. (2023). Supratentorial CNS-PNETs in children; a Swedish population-based study with molecular re-evaluation and long-term follow-up. Clinical Epigenetics. 15(1). 40–40. 1 indexed citations
2.
Lagerstedt‐Robinson, Kristina, Fulya Taylan, Bianca Tesi, et al.. (2023). Register-based and genetic studies of Prader-Willi syndrome show a high frequency of gonadal tumors and a possible mechanism for tumorigenesis through imprinting relaxation. Frontiers in Medicine. 10. 1172565–1172565.
3.
Pietsch, Torsten, Thomas Olsson Bontell, Teresia Kling, et al.. (2022). DNA methylation profiling improves routine diagnosis of paediatric central nervous system tumours: A prospective population‐based study. Neuropathology and Applied Neurobiology. 48(6). e12838–e12838. 16 indexed citations
4.
Rask, Olof, Fredrik Nilsson, Päivi M. Lähteenmäki, et al.. (2022). Prospective registration of symptoms and times to diagnosis in children and adolescents with central nervous system tumors: A study of the Swedish Childhood Cancer Registry. Pediatric Blood & Cancer. 69(11). e29850–e29850. 5 indexed citations
5.
Slavc, Irene, Lisa Mayr, Johannes Gojo, et al.. (2022). Improved Long-Term Survival of Patients with Recurrent Medulloblastoma Treated with a “MEMMAT-like” Metronomic Antiangiogenic Approach. Cancers. 14(20). 5128–5128. 20 indexed citations
6.
Slavc, Irene, Andreas Peyrl, Johannes Gojo, et al.. (2020). MBCL-43. RECURRENT MEDULLOBLASTOMA – LONG-TERM SURVIVAL WITH A “MEMMAT” BASED ANTIANGIOGENIC APPROACH. Neuro-Oncology. 22(Supplement_3). iii397–iii397. 4 indexed citations
7.
Hargrave, Darren, Olaf Witt, Kenneth J. Cohen, et al.. (2018). Phase II open-label, global study evaluating dabrafenib in combination with trametinib in pediatric patients with BRAF V600–mutant high-grade glioma (HGG) or low-grade glioma (LGG). Annals of Oncology. 29. viii132–viii132. 6 indexed citations
8.
Gool, Stefaan Van, Stefan Holm, Lars Adamson, et al.. (2016). Immunotherapy in atypical teratoid-rhabdoid tumors: Data from a survey of the HGG-Immuno Group. Cytotherapy. 18(9). 1178–1186. 16 indexed citations
9.
Holm, Stefan, C Balé, Stephanie G. Burton, et al.. (2016). When should placebo surgery as a control in clinical trials be carried out?. Bulletin of The Royal College of Surgeons of England. 98(2). 75–79. 15 indexed citations
10.
11.
Valanne, Leena, Tuula Lönnqvist, Stefan Holm, et al.. (2014). Radiation therapy and concurrent topotecan followed by maintenance triple anti-angiogenic therapy with thalidomide, etoposide, and celecoxib for pediatric diffuse intrinsic pontine glioma. Pediatric Blood & Cancer. 61(9). 1603–1609. 20 indexed citations
12.
Bartuma, Katarina, et al.. (2013). A 10‐year experience of outcome in chemotherapy‐treated hereditary retinoblastoma. Acta Ophthalmologica. 92(5). 404–411. 37 indexed citations
13.
Giraud, G, Torbjörn Ramqvist, Diana V. Pastrana, et al.. (2009). DNA from KI, WU and Merkel Cell Polyomaviruses Is Not Detected in Childhood Central Nervous System Tumours or Neuroblastomas. PLoS ONE. 4(12). e8239–e8239. 26 indexed citations
14.
Lannering, Birgitta, Per‐Erik Sandström, Stefan Holm, et al.. (2009). Classification, incidence and survival analyses of children with CNS tumours diagnosed in Sweden 1984–2005. Acta Paediatrica. 98(10). 1620–1627. 91 indexed citations
15.
Baryawno, Ninib, Baldur Sveinbjørnsson, Staffan Eksborg, et al.. (2008). Tumor-growth–promoting cyclooxygenase-2 prostaglandin E2 pathway provides medulloblastoma therapeutic targets. Neuro-Oncology. 10(5). 661–674. 61 indexed citations
16.
Lafay‐Cousin, Lucie, Stefan Holm, Ibrahim Qaddoumi, et al.. (2005). Weekly vinblastine in pediatric low‐grade glioma patients with carboplatin allergic reaction. Cancer. 103(12). 2636–2642. 65 indexed citations
17.
Gray, Steven G., Therése Eriksson, Stefan Holm, et al.. (2000). Altered expression of members of the IGF-axis in hepatoblastomas. British Journal of Cancer. 82(9). 1561–1567. 37 indexed citations
18.
Gray, Steven G., Wolfgang Hartmann, Therése Eriksson, et al.. (2000). Expression of genes involved with cell cycle control, cell growth and chromatin modification are altered in hepatoblastomas.. International Journal of Molecular Medicine. 6(2). 161–9. 9 indexed citations
19.
Tidehag, Per, A.-S. Sandberg, Göran Hallmans, et al.. (1995). Effect of milk and fermented milk on iron absorption in ileostomy subjects. American Journal of Clinical Nutrition. 62(6). 1234–1238. 18 indexed citations
20.
Holm, Stefan, et al.. (1990). MACROMOLECULAR ABSORPTION DURING AND AFTER GASTROENTERITIS IN CHILDREN. Pediatric Research. 27(5). 534–534.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Neofytos Prodromou Breakdown of academic impact, for papers by Steven Rostad Breakdown of academic impact, for papers by M Zavanone Breakdown of academic impact, for papers by Peter Milos Breakdown of academic impact, for papers by Antonio E. Frias Breakdown of academic impact, for papers by S. Ali Nabavizadeh Breakdown of academic impact, for papers by Shyamala Navada Breakdown of academic impact, for papers by Martha Lilia Tena‐Suck Breakdown of academic impact, for papers by Louise Carstam
Rankless by CCL
2026